CN103638062B - Dashing agent of a kind of anti-dermatophytosis and preparation method thereof - Google Patents
Dashing agent of a kind of anti-dermatophytosis and preparation method thereof Download PDFInfo
- Publication number
- CN103638062B CN103638062B CN201310715668.XA CN201310715668A CN103638062B CN 103638062 B CN103638062 B CN 103638062B CN 201310715668 A CN201310715668 A CN 201310715668A CN 103638062 B CN103638062 B CN 103638062B
- Authority
- CN
- China
- Prior art keywords
- galla
- agent
- extract
- mixed solvent
- pouring agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 11
- 208000002474 Tinea Diseases 0.000 title description 8
- 206010012504 Dermatophytosis Diseases 0.000 title description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 25
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 230000000629 anti-dermatophyte Effects 0.000 claims abstract description 7
- 239000012046 mixed solvent Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000004540 pour-on Substances 0.000 claims description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 235000013772 propylene glycol Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 3
- NMKVYLJBDOVKTM-UHFFFAOYSA-N 3-(2-hydroxyethyl)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1CC2(C)C(O)(CCO)CC1C2(C)C NMKVYLJBDOVKTM-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 239000007788 liquid Substances 0.000 abstract description 9
- 206010017533 Fungal infection Diseases 0.000 abstract description 7
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 208000007163 Dermatomycoses Diseases 0.000 abstract description 5
- 239000012752 auxiliary agent Substances 0.000 abstract description 4
- 208000024386 fungal infectious disease Diseases 0.000 abstract description 4
- 231100001231 less toxic Toxicity 0.000 abstract description 4
- 230000005923 long-lasting effect Effects 0.000 abstract description 4
- 208000031888 Mycoses Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 239000006185 dispersion Substances 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000002075 main ingredient Substances 0.000 abstract description 2
- 239000003961 penetration enhancing agent Substances 0.000 abstract description 2
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 27
- 229940079593 drug Drugs 0.000 description 19
- 238000000034 method Methods 0.000 description 10
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 208000024963 hair loss Diseases 0.000 description 5
- 230000003676 hair loss Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241001480043 Arthrodermataceae Species 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241001480037 Microsporum Species 0.000 description 4
- 241000893980 Microsporum canis Species 0.000 description 4
- 241001460074 Microsporum distortum Species 0.000 description 4
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- 206010067482 No adverse event Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241000893966 Trichophyton verrucosum Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000219000 Populus Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241001135911 Saltella Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001516602 Schlechtendalia chinensis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
一种抗皮肤癣菌的浇泼剂,其特征在于:该浇泼剂按每100ml混合溶剂溶解0.56g~5g的五倍子提取物的比例制成,所述100ml混合溶剂由以下量的组分组成:透皮促进剂2ml~6ml,增溶剂0.5ml~2ml,溶剂30ml~50ml,余量为辅助剂。经本发明制得的浇泼剂,主药分散均匀,透明稍黏稠液体,给药方便、持效长、毒副作用小,符合中国药典要求,质量可控。本发明经药效学研究表明,对于因皮肤癣菌感染所致的皮肤真菌病具有预防与治疗作用,对于因真菌感染而继发的炎症有辅助治疗作用。A pouring agent for anti-dermatophytes, characterized in that: the pouring agent is made according to the ratio of dissolving 0.56g to 5g of Galla gall extract per 100ml mixed solvent, and the 100ml mixed solvent consists of the following components : Penetration enhancer 2ml~6ml, solubilizer 0.5ml~2ml, solvent 30ml~50ml, the balance is auxiliary agent. The pouring agent prepared by the invention has uniform dispersion of main ingredients, transparent and slightly viscous liquid, convenient administration, long-lasting effect, less toxic and side effects, meets the requirements of Chinese Pharmacopoeia, and has controllable quality. Pharmacodynamic studies show that the present invention has preventive and therapeutic effects on skin mycosis caused by dermatophyte infection, and has auxiliary therapeutic effect on secondary inflammation caused by fungal infection.
Description
技术领域 technical field
本发明涉及一种抗皮肤癣菌的浇泼剂及其制备方法,具体涉及一种用于防治皮肤癣菌感染所致的皮肤真菌病中药浇泼剂及其制备方法。 The invention relates to an anti-dermatophyte pour-on and a preparation method thereof, in particular to a traditional Chinese medicine pour-on for preventing and treating dermatophytosis caused by dermatophyte infection and a preparation method thereof.
背景技术 Background technique
皮肤癣菌是由丝状真菌侵入皮肤角质层及其附属物所引起的危害动物养殖业的疾病之一。具有高度传染性的人畜共患接触性皮肤病,又被称为“脱毛癣”。本病主要侵害动物皮毛,出现皮屑增多、结痂、脱毛、渗出、毛囊炎及痒感等症状,严重的可引起机体营养不良、生长迟缓、饲料报酬降低等,直接影响皮毛的产量和品质,降低动物的生产性能和幼仔的成活率,给养殖业造成了严重的经济损失。 Dermatophyte is one of the diseases harmful to the animal breeding industry caused by filamentous fungus invading the cuticle of the skin and its appendages. Highly contagious zoonotic contact skin disease, also known as "dermatophytosis". This disease mainly affects animal fur, and symptoms such as increased dander, scab, hair loss, exudation, folliculitis and itching appear, and severe cases can cause body malnutrition, growth retardation, and reduced feed remuneration, which directly affect the output and quality of fur. Quality, reduce the production performance of animals and the survival rate of cubs, causing serious economic losses to the breeding industry.
真菌皮癣病的治疗方法有一般治疗法、中西结合治疗方法、物理治疗方法三种,而鉴于广谱抗菌药、免疫抑制剂、放化疗药物的广泛应用,真菌的耐药性越来越强,因此上述治疗方法中最为有效的方法为中西结合治疗方法。在这种情况下,研制毒副作用小、不易产生耐药性、对环境影响小的抗真菌天然产物成为必然趋势,寻找和利用药用植物中天然抗真菌活性成分为母体设计新型抗真菌药物就成为研究与开发的新热点。单方或复方中药的外用疗效明显、抗菌效果好,在真菌感染及混合性感染的治疗上疗效明显。 The treatment methods for fungal skin ringworm include general treatment, combination of traditional Chinese and western medicine, and physical therapy. In view of the wide application of broad-spectrum antibacterial drugs, immunosuppressants, and chemoradiotherapy drugs, the drug resistance of fungi is becoming stronger and stronger. Therefore, the most effective method among the above-mentioned treatment methods is the combination of Chinese and Western medicine. In this case, it is an inevitable trend to develop antifungal natural products with less toxic side effects, less drug resistance, and less environmental impact. It is necessary to find and use natural antifungal active ingredients in medicinal plants as the parent to design new antifungal drugs. Become a new hotspot of research and development. Single or compound traditional Chinese medicine has obvious curative effect and good antibacterial effect for external use, and has obvious curative effect in the treatment of fungal infection and mixed infection.
五倍子(Gallnut)为漆树科植物盐肤木、青麸杨或红麸杨叶上的虫瘿,主要由五倍子蚜(Melaphischinensis(Bell)Baker)寄生而形成。其主要活性成分单宁酸是一种水溶性多酚化合物,兼备抗氧化、抗菌、抗病毒、抗肿瘤多种活性。五倍子常与其他多种中药一起用于治疗皮肤癣病,其复方工艺复杂,成本高。 Gallnut is the gall on the leaves of the Anacardiaceae plant Saltella , Populus chinensis or Populus red bran, which is mainly formed by the gallnut aphid ( Melaphischinensis (Bell)Baker). Its main active ingredient, tannic acid, is a water-soluble polyphenolic compound with multiple activities of antioxidant, antibacterial, antiviral, and antitumor. Gallnut is often used to treat skin ringworm together with other various traditional Chinese medicines, and its compound process is complicated and the cost is high.
发明内容 Contents of the invention
本发明的目的是鉴于现有抗真菌西药的毒副作用及昂贵的价格以及复方工艺的复杂性,提供一种对皮肤癣菌菌杀灭作用显著,毒副作用小、成本低廉、工艺简单的治疗皮肤癣菌感染所致皮肤真菌病的浇泼剂及其制备方法。 The purpose of the present invention is to provide a kind of anti-dermatophytes that has significant killing effect on dermatophytes, less toxic and side effects, low cost and simple process in view of the toxic and side effects of the existing antifungal western medicines and the high price and the complexity of the compound process. A pouring agent for skin mycosis caused by ringworm infection and a preparation method thereof.
本发明采用了中药五倍子提取物,致力研究出一种疗效显著、毒副作用小、成本低、工艺简单的外用治疗皮肤癣菌感染所致皮肤真菌病的浇泼剂。 The present invention adopts the extract of the Chinese medicine Galla chinensis, and strives to develop an external pouring agent for treating skin mycosis caused by dermatophyte infection with remarkable curative effect, low toxic and side effects, low cost and simple process.
本发明的目的通过以下技术方案来实施:一种抗皮肤癣菌的浇泼剂,以单味中药提取物为主药,在透皮促进剂等辅剂的作用下,使其均匀地分散于基质中形成灰白色的稍黏稠的单味中药液体制剂。具体为: The object of the present invention is implemented through the following technical solutions: a kind of anti-dermatophyte pouring agent, with single Chinese medicine extract as the main agent, under the effect of auxiliary agents such as transdermal accelerators, it is evenly dispersed in A slightly viscous off-white liquid preparation of single traditional Chinese medicine is formed in the matrix. Specifically:
一种抗皮肤癣菌的浇泼剂,该浇泼剂按每100ml混合溶剂溶解0.56g~5g的五倍子提取物的比例制成,所述100ml混合溶剂由以下量的组分组成: A kind of anti-dermatophyte pour-on agent, this pour-on agent is made according to the ratio of the Galla gall extract of 0.56g~5g per 100ml mixed solvent is dissolved, and described 100ml mixed solvent is made up of the following components:
透皮促进剂2ml~6ml Transdermal accelerator 2ml~6ml
增溶剂0.5ml~2ml Solubilizer 0.5ml~2ml
溶剂30ml~50ml Solvent 30ml~50ml
辅助剂余量。 Auxiliary balance.
所述五倍子提取物由以下制备方法制得:取五倍子碎粉过20目筛得粗粉,将粗分用20倍量50%乙醇在60℃条件下超声波提取30min,过滤将滤液浓缩至糊状,放入55℃烘箱中,直至烘干到恒重,得五倍子提取物。 The Galla galla extract is prepared by the following preparation method: Take Galla galla powder and pass it through a 20-mesh sieve to obtain a coarse powder, use 20 times the amount of 50% ethanol to ultrasonically extract at 60°C for 30 minutes, filter and concentrate the filtrate to a paste , and put it in an oven at 55°C until it is dried to a constant weight to obtain Galla gall extract.
所述透皮促进剂为氮酮,0.5%冰片乙醇溶液,1%十二烷基磺酸钠水溶液中的一种或多种。 The skin penetration enhancer is one or more of azone, 0.5% borneol ethanol solution, and 1% sodium dodecylsulfonate aqueous solution.
所述增溶剂为吐温-80和/或司盘。 The solubilizer is Tween-80 and/or Span.
所述溶剂为1,2-丙二醇。 The solvent is 1,2-propanediol.
所述辅助剂为60-100%乙醇。 The auxiliary agent is 60-100% ethanol.
本发明中: In the present invention:
1)采用正交试验法优化透皮促进剂、增溶剂、溶剂和主药的配比,涉及全面、操作简单。 1) The ratio of transdermal enhancer, solubilizer, solvent and main drug is optimized by orthogonal test method, which is comprehensive and easy to operate.
2)辅助剂乙醇补足剩余的体积,达到药物发挥疗效的浓度水平。 2) The auxiliary agent ethanol makes up the remaining volume to reach the concentration level for the drug to exert its curative effect.
3)按一定的稀释方法稀释各水平的浇泼剂,在一定的波长条件下测定其吸光度,确定五倍子浇泼剂的最佳配比方法。 3) Dilute each level of pouring agent according to a certain dilution method, measure its absorbance under a certain wavelength condition, and determine the best ratio method of Galla gall pouring agent.
本发明的浇泼剂对人和动物及环境安全。本发明的浇泼剂为液体制剂,其特点是灰白色,稍黏稠液体;制备工艺简单、给药方便、持效性长;用时稀释一定倍数后浇泼于机体,在透皮促进剂的帮助下,药物透过皮肤进入机体到达靶器官发挥疗效。 The pouring agent of the present invention is safe to humans, animals and the environment. The pouring agent of the present invention is a liquid preparation, which is characterized by off-white, slightly viscous liquid; the preparation process is simple, the administration is convenient, and the long-lasting effect; when used, it is diluted by a certain multiple and then poured on the body. , The drug enters the body through the skin and reaches the target organ to exert its curative effect.
由于治疗皮肤真菌病的外用药通常经皮渗透量很少,我们将其制成一种含有透皮促进剂、给药方便、持效性长的液体制剂,以利于药物较多的渗透皮肤,与真菌接触从而发挥作用。溶剂1,2-丙二醇对氮酮具有协同促进的作用,它的加入更加能促进药物渗透皮肤,使其避免了一般外用制剂药物利用率低的缺点,更好的发挥治疗作用。因此,本发明的浇泼剂渗透性好,吸收率高,有利于药物进入皮肤,提高了药效。 Since external medicines for the treatment of dermatophytosis usually have very little transdermal penetration, we make them into a liquid preparation containing a transdermal enhancer, which is convenient for administration and has a long-lasting effect, so as to facilitate more penetration of the drug into the skin. Comes into contact with the fungus to function. The solvent 1,2-propanediol has a synergistic promoting effect on azone, and its addition can promote the penetration of the drug into the skin, so that it avoids the shortcoming of low drug utilization rate of general external preparations, and better exerts the therapeutic effect. Therefore, the pouring agent of the present invention has good permeability and high absorption rate, which is beneficial for medicines to enter the skin and improves the efficacy of medicines.
经本发明制得的浇泼剂,主药分散均匀,透明稍黏稠液体,给药方便、持效长、毒副作用小,符合中国药典要求,质量可控。 The pouring agent prepared by the invention has uniform dispersion of main ingredients, transparent and slightly viscous liquid, convenient administration, long-lasting effect, less toxic and side effects, meets the requirements of Chinese Pharmacopoeia, and has controllable quality.
本发明经药效学研究表明,对于因皮肤癣菌感染所致的皮肤真菌病具有预防与治疗作用,对于因真菌感染而继发的炎症有辅助治疗作用。 Pharmacodynamic studies show that the present invention has preventive and therapeutic effects on skin mycosis caused by dermatophyte infection, and has auxiliary therapeutic effect on secondary inflammation caused by fungal infection.
具体实施方式 detailed description
以下通过具体实施例来进一步说明本发明,但实施例仅用于说明并不能限制本发明的范围。 The present invention is further described by specific examples below, but the examples are only for illustration and cannot limit the scope of the present invention.
实施例1 Example 1
取0.56g的五倍子中药浸膏溶于30ml的1,2-丙二醇中,然后相继加入2ml氮酮、1ml吐温-80、67ml90%乙醇,混匀即可;然后将其制得的成品分装于小瓶中密封,每瓶大约5~20ml。经检测,本浇泼剂性状为灰白色、透明稍粘稠液体,酸碱度、装量、微生物限度均合格。 Take 0.56g gallic gall extract and dissolve it in 30ml of 1,2-propanediol, then add 2ml of azone, 1ml of Tween-80, 67ml of 90% ethanol in succession, and mix well; then divide the finished product Sealed in vials, about 5~20ml per bottle. After testing, the properties of this pouring agent are off-white, transparent and slightly viscous liquid, and the pH, loading capacity and microbial limit are all qualified.
实施例2 Example 2
取1.67g的五倍子中药浸膏溶于40ml的1,2-丙二醇中,然后相继加入4ml氮酮、0.5ml吐温-80、55.5ml90%乙醇,混匀即可;然后将其制得的成品分装于小瓶中密封,每瓶大约5~20ml。经检测,本浇泼剂性状为灰白色、透明稍粘稠液体,酸碱度、装量、微生物限度均合格。 Dissolve 1.67g of Galla Chinese medicinal extract in 40ml of 1,2-propanediol, then add 4ml of azone, 0.5ml of Tween-80, 55.5ml of 90% ethanol in succession, and mix well; then the finished product Packed in vials and sealed, about 5~20ml per bottle. After testing, the properties of this pouring agent are off-white, transparent and slightly viscous liquid, and the pH, loading capacity and microbial limit are all qualified.
实施例3 Example 3
取5g的五倍子中药浸膏溶于50ml的1,2-丙二醇中,然后相继加入6ml氮酮、2ml吐温-80、42ml90%乙醇,混匀即可;然后将其制得的成品分装于小瓶中密封,每瓶大约5~20ml。经检测,本浇泼剂性状为灰白色、透明稍粘稠液体,酸碱度、装量、微生物限度均合格。 Take 5g of Galla Chinese medicinal extract and dissolve it in 50ml of 1,2-propylene glycol, then add 6ml of azone, 2ml of Tween-80, and 42ml of 90% ethanol in succession, and mix well; then distribute the finished product in Sealed in vials, about 5~20ml per bottle. After testing, the properties of this pouring agent are off-white, transparent and slightly viscous liquid, and the pH, loading capacity and microbial limit are all qualified.
1、对实施例1-实施例3所制得的浇泼剂进行了如下抗皮肤癣药效试验: 1, the pouring agent that embodiment 1-embodiment 3 makes has carried out following anti-dermatophyte drug efficacy test:
试验温度20℃,重复3次,浇泼剂100%浓度对白色念珠球菌、须癣毛癣菌、犬小孢子菌以及石膏样小孢子菌作用20min,杀灭效果见表1。 The test temperature was 20°C, repeated 3 times, and the concentration of 100% pouring agent was used to act on Candida albicans, Trichophyton mentagrophytes, Microsporum canis and Microsporum gypsum for 20 minutes. The killing effect is shown in Table 1.
表1实施例1-实施例3所制得的浇泼剂对白色念珠球菌、须癣毛癣菌、犬小孢子菌以及石膏样小孢子菌的杀灭效果。 Table 1 The killing effect of the pouring agents prepared in Examples 1-3 on Candida albicans, Trichophyton mentagrophytes, Microsporum canis and Microsporum gypsumoides.
2、实施例2所制得的五倍子提取物浇泼剂对白色念珠球菌、须癣毛癣菌、犬小孢子菌以及石膏样小孢子菌四株真菌的MIC和MFC值为: 2. The MIC and MFC values of the Galla gall extract pouring agent made in Example 2 to Candida albicans, Trichophyton mentagrophytes, Microsporum canis and Microsporum gypsum-like four fungi are:
对白色念珠球菌的MIC和MFC值分别为0.0125mg/ml、0.05mg/ml; The MIC and MFC values against Candida albicans are 0.0125mg/ml and 0.05mg/ml respectively;
对须癣毛癣菌的MIC和MFC值分别为0.025mg/ml、0.05mg/ml; The MIC and MFC values for Trichophyton mentagrophytes are 0.025mg/ml and 0.05mg/ml respectively;
对犬小孢子菌的MIC和MFC值分别为0.025mg/ml、0.025mg/ml; The MIC and MFC values against Microsporum canis are 0.025mg/ml and 0.025mg/ml respectively;
对石膏样小孢子菌的MIC和MFC值分别为0.025mg/ml、0.05mg/ml。 The MIC and MFC values against Microsporum gypsumoides are 0.025mg/ml and 0.05mg/ml, respectively.
3、临床症状观察 3. Observation of clinical symptoms
选取感染皮肤癣菌的家兔50只,随机分成5组(Ⅰ组空白对照组、Ⅱ组达克宁霜治疗对照组、Ⅲ组实施例1治疗组、Ⅳ组实施例2治疗组、Ⅴ组实施例3治疗组),每组10只;使用方法:将患处清洗干净,然后取治疗药剂适量涂抹患处皮肤,2次/天,连续使用14天观察疗效,统计有效率;停药后1-5天统计治愈率,停药后10-15天统计复发率。用药前,感染皮肤癣菌的家兔,背部、耳部、四肢等处出现皮损,存在红斑和严重的脱毛现象;用药14天后,各组疗效为: Select 50 rabbits infected with dermatophytes, and randomly divide them into 5 groups (group I blank control group, group II dacryline cream treatment control group, group III example 1 treatment group, group IV example 2 treatment group, group V example 3 treatment groups), 10 rats in each group; method of use: clean the affected area, then take an appropriate amount of therapeutic agent and apply it to the skin of the affected area, 2 times/day, use continuously for 14 days to observe the curative effect and count the effective rate; 1-5 days after stopping the drug The cure rate was counted, and the recurrence rate was counted 10-15 days after drug withdrawal. Before the medication, the rabbits infected with dermatophytes had skin lesions on the back, ears, limbs, etc., with erythema and severe hair loss; after 14 days of medication, the curative effects of each group were as follows:
Ⅰ组空白对照组:皮损处仍存在红斑和严重的脱毛现象,个别出现微量皮屑;感染皮肤癣菌症状无任何改善。 Group Ⅰ blank control group: erythema and severe hair loss still existed in the skin lesions, and a small amount of dander appeared in some cases; the symptoms of dermatophyte infection did not improve.
Ⅱ组达克宁霜治疗对照组:用药14天后,皮损处红斑和脱毛现象消失,且长出新的毛发。停药后1-5天统计治愈90%,停药后10-15天统计复发率10%。 Group II Daknine cream treatment control group: after 14 days of treatment, the erythema and hair loss in the skin lesions disappeared, and new hair grew. 1-5 days after drug withdrawal, 90% were cured, and 10-15 days after drug withdrawal, the recurrence rate was 10%.
Ⅲ组实施例1治疗组:用药14天后,皮损处红斑和脱毛现象基本消失,患处偶有新生的被毛长出,未出现不良反应,有效率70%;停药后1-5天统计治愈60%,停药后10-15天统计复发率30%。 Group III Example 1 Treatment group: after 14 days of medication, erythema and hair loss in the skin lesions basically disappeared, and occasionally new hairs grew out of the affected area, no adverse reactions occurred, and the effective rate was 70%; statistics were collected 1-5 days after stopping the drug 60% were cured, and the statistical recurrence rate was 30% in 10-15 days after drug withdrawal.
Ⅳ组实施例2治疗组:用药14天后,皮损处红斑和脱毛现象消失,患处有新生的被毛长出,未出现不良反应,有效率90%;停药后1-5天统计治愈90%,停药后10-15天统计复发率10%。 Group IV, Example 2 Treatment group: after 14 days of medication, erythema and depilation at the skin lesion disappeared, new hairs grew out of the affected area, no adverse reactions occurred, and the effective rate was 90%; 90% were cured 1-5 days after drug withdrawal %, the statistical recurrence rate was 10% 10-15 days after drug withdrawal.
Ⅴ组实施例3治疗组:用药14天后,皮损处红斑和脱毛现象消失,患处有新生的被毛长出,未出现不良反应,有效率90%;停药后1-5天统计治愈90%,停药后10-15天统计复发率10%。 Group V and Example 3 Treatment group: after 14 days of medication, erythema and depilation at the skin lesion disappeared, new hairs grew out of the affected area, no adverse reactions occurred, and the effective rate was 90%; 90% were cured 1-5 days after drug withdrawal %, the statistical recurrence rate was 10% 10-15 days after drug withdrawal.
由此可知,与空白对照组相比较,实施例2和实施例3浇泼剂均有很好的疗效,实施例1浇泼剂具有一定疗效;与阳性药物达克宁霜比较,实施例2和实施例3浇泼剂已起到相同的治疗效果,可以用于临床治疗家兔真菌皮癣病。 It can be seen that, compared with the blank control group, the pour-on formulations of embodiment 2 and embodiment 3 all have a good curative effect, and the pour-on formulation of embodiment 1 has a certain curative effect; Example 3 pouring agent has played the same therapeutic effect, and can be used for clinical treatment of rabbit fungal dermatophytosis.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310715668.XA CN103638062B (en) | 2013-12-23 | 2013-12-23 | Dashing agent of a kind of anti-dermatophytosis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310715668.XA CN103638062B (en) | 2013-12-23 | 2013-12-23 | Dashing agent of a kind of anti-dermatophytosis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103638062A CN103638062A (en) | 2014-03-19 |
CN103638062B true CN103638062B (en) | 2016-04-13 |
Family
ID=50243434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310715668.XA Expired - Fee Related CN103638062B (en) | 2013-12-23 | 2013-12-23 | Dashing agent of a kind of anti-dermatophytosis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103638062B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115671285B (en) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | Antifungal solution and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526117A (en) * | 2012-02-06 | 2012-07-04 | 同济大学 | Purpose of nutgall used for preparing antifungal medicine and antifungal medicine synergistic agent |
-
2013
- 2013-12-23 CN CN201310715668.XA patent/CN103638062B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526117A (en) * | 2012-02-06 | 2012-07-04 | 同济大学 | Purpose of nutgall used for preparing antifungal medicine and antifungal medicine synergistic agent |
Non-Patent Citations (1)
Title |
---|
中草药抗真菌的研究进展;党小利;《现代医药卫生》;20081231;第24卷(第10期);第1513-1514页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103638062A (en) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110538313B (en) | Broad-spectrum malassezia-resistant natural product composition and application | |
CN101843637B (en) | External spray for preventing and treating beriberi and preparation method | |
Farasati Far et al. | The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectives | |
AU2008203101A1 (en) | Topical compositions comprising telmesteine for treating dermatological disorders | |
WO2014118040A1 (en) | Extract from indigo tinctoria for the topical treatment and prophylaxis of skin disorders | |
CN109432201B (en) | Gynecological antibacterial gel and preparation method thereof | |
US9545429B1 (en) | Homeopathic formulations | |
CN103638062B (en) | Dashing agent of a kind of anti-dermatophytosis and preparation method thereof | |
CN102274286A (en) | Cinnamomum longepaniculatum leaf volatile oil clathrate compound and preparation method thereof | |
CN105395562A (en) | External use emulsifiable paste for treating skin diseases and with econazole nitrate and triamcinolone acetonide as active components and preparation method | |
CN102526070A (en) | Compound bifonazole nano-emulsion spray preparation and preparation method thereof | |
US9161961B2 (en) | Therapeutic compositions | |
CN105287692A (en) | Dalbergia benthami prain extractive, and preparation method and application thereof | |
CN103157071B (en) | Chinese herbal compound film for treating dermatomycosis and preparation method thereof | |
CN103638112A (en) | Eucalyptus oil solution and preparation method thereof | |
CN106511478A (en) | Compound essential oil for treating dog tinea as well as preparation method and applications of compound essential oil | |
CN104856977A (en) | Externally-used film coating agent for treating fungal infection type dermatosis attacking cattle and sheep | |
CN106668004A (en) | Edaravone and (+)2-camphol liniment and preparation method thereof | |
CN108079050A (en) | Herbal skin bacteria inhibiting composition and preparation method and application | |
CN112386539A (en) | Shampoo product with effects of recovering scalp itching and desquamation | |
CN105395471A (en) | External use emulsifiable paste for treating skin diseases and with econazole nitrate as active component and preparation method | |
CN110772572A (en) | Senden-4 lotion and preparation method thereof | |
Aaliya et al. | A randomized active controlled clinical trial to evaluate safety and efficacy of a topical unani formulation marham kharish jadeed in the management of qūbā (tinea corporis) | |
CN111228259A (en) | Medicinal uses of 5-hydroxy-1-methyl hydantoin | |
WO2019039964A1 (en) | Antibacterial composition to deliver gramicidin c to a site of local inflammation, method of producing an antibacterial composition to deliver gramicidin c to a site of local inflammation, and method of delivering gramicidin c to a site of local inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160309 Address after: 625014 Sichuan Agricultural Uniersity, Sichuan, Ya'an No. 46 Applicant after: SICHUAN AGRICULTURAL University Applicant after: SICHUAN TAIXIN ANIMAL PHARMACEUTICAL Co.,Ltd. Address before: 625014 Sichuan Agricultural Uniersity, Sichuan, Ya'an No. 46 Applicant before: Sichuan Agricultural University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160413 |
|
CF01 | Termination of patent right due to non-payment of annual fee |